Life Sciences

Healthcare

Totus Medicines Names Zelanna Goldberg CMO

Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, announced the initiation of an indication...

Healthcare

Ovation.io Unveils Data on Genome Sequences & GLP-1 Use

Ovation.io, a leading provider of research-focused data solutions, announced the launch of a groundbreaking research data set that combines whole genome sequencing (WGS) data...

Life Sciences

OMNY Health & Scipher Medicine Revolutionize Autoimmune Treatment

OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which has the world’s largest immunology clinico-transcriptomics data...

Healthcare

Prudentia Sciences Secures $7M to Transform Life Sciences Dealmaking

Prudentia Sciences, an AI-powered technology platform for life sciences announced its public launch, supported by $7 million in funding. The funding round was led...

Healthcare

Tempus Partners With Genialis for RNA Biomarker Algorithms

Tempus AI, Inc, a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration with Genialis, the...

Healthcare

ONCare Partners with Ovation.io for Oncology Biomarker Database

This collaboration combines real world clinical EMR data from a large footprint of cancer centers with research grade multi-omics data collected at key treatment...

Healthcare

Deciphex Raises $32.3M Series C to Tackle Pathology Shortage

Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising $32.3 million to address the acute global pathology crisis. Led...

Life Sciences

PostEra Expands AI Drug Discovery Deal with Pfizer to $610M

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced an expansion of their partnership with Pfizer. The parties will launch...

Healthcare

Iambic Therapeutics Appoints Michael Secora as CFO & CDO

Iambic Therapeutics, a clinical-stage biotechnology company developing novel medicines using its AI-driven discovery and development platform, announced that Michael Secora, Ph.D. will be its...

Healthcare

iBio Expands Cardiometabolic Program with Anti-Myostatin In-Licensed from AstralBio

iBio, Inc., an AI-driven innovator of precision antibody immunotherapies, announced the expansion of its cardiometabolic and obesity treatment development program by in-licensing a potentially...